COMMUNIQUÉS West-GlobeNewswire

NewLink Genetics Presents Updated NLG802 Results at the Immuno-Oncology 2019 World Congress
23/05/2019
NLG802, a prodrug of indoximod, produced significantly higher pharmacokinetic (PK) exposure in patients compared to molar equivalent of indoximod while maintaining encouraging safety profile Notable response in 5 th [...]
Mustang Bio and St. Jude Children’s Research Hospital to Participate in Panel Discussion at Boston CEO 2019
23/05/2019
NEW YORK, and MEMPHIS, Tenn., May 23, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and [...]
Acer Therapeutics to Present at Upcoming Investor Conferences
23/05/2019
NEWTON, Mass., May 23, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life- [...]
Obalon Therapeutics, Inc. Prices $3,000,000 Registered Direct Offering
23/05/2019
SAN DIEGO, May 23, 2019 (GLOBE NEWSWIRE) -- OBALON THERAPEUTICS, INC. (NASDAQ: OBLN) (“Obalon” or the “Company”) , a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas [...]
Dentsply Sirona to Present at the Stifel 2019 Dental & Veterinary Conference on May 29th
23/05/2019
CHARLOTTE, N.C., May 23, 2019 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced that it will participate in the Stifel 2019 Dental & [...]
XBiotech Announces Plan to Launch Randomized Phase 2b Study of Bermekimab in Hidradenitis Suppurativa
23/05/2019
AUSTIN, Texas, May 23, 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced plans to advance its dermatology program for its true human antibody bermekimab with the launch of a randomized, double-blind, placebo [...]
PSIQ Aiming to Significantly Bolster Revenues and Market Share by Attending Champs Trade Show, the Premier Counterculture B2B Expo at Atlantic City, New Jersey Convention Center May 21st, 2019 Through May 23rd, 2019
23/05/2019
SUNRISE, Fla., May 23, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ ) through its subsidiary Elite Products International, Inc. (“Elite”) announces it is attending Champs Trade Show, the premier [...]
Avricore Health Inc. Installs New CFO and Corporate Secretary
23/05/2019
Kevin Strong will serve as CFO and Deena Siblock takes on Corporate Secretary role, adding capacity and talent to the fast-growing healthcare technology leader, Avricore Health. Vancouver, May 23, 2019 (GLOBE NEWSWIRE [...]
TYME and The Joseph Ahmed Foundation Announce Initiation of the HopES Phase II Trial Evaluating the Potential Benefits of SM-88 for Patients with High-Risk Sarcomas
23/05/2019
New oral approach aimed at disrupting cancer metabolism in high-risk sarcomas; 12,000 cases annually in U.S. alone SM-88 (racemetyrosine) is an oral, investigational cancer metabolism-based therapy that has demonstrated [...]
Merus Announces 2019 Annual General Meeting of Shareholders
23/05/2019
UTRECHT, The Netherlands, May 23, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length human [...]
Alverno Laboratories goes digital with Philips to innovate pathology services
23/05/2019
May 23, 2019 Large Midwest laboratory selects Philips IntelliSite Pathology Solution to further enhance efficiencies and quality of diagnostics for histology cases Amsterdam, The Netherlands and Hammond, Ind. – Royal [...]
IntelGenx to Join the Quebec Pavilion at BIO 2019 International Convention
23/05/2019
SAINT LAURENT, Quebec, May 23, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), leader in pharmaceutical films, today announced that it will be joining the Quebec Pavilion at Booth #2627 [...]
AzurRx BioPharma Reaches Enrollment Target for Phase II OPTION Clinical Trial
23/05/2019
Enrollment in AzurRx’s Phase II OPTION study has reached target of 30-35 patients Screening activities have been completed in AzurRx’s Phase II Option study Top-line data expected in Summer 2019 NEW YORK, May 23, 2019 ( [...]
Todos Medical Receives Approval from Israeli Ministry of Health (AMAR) to Market and Sell its Breast Cancer Screens in Israel
23/05/2019
REHOVOT, Israel, May 23, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and [...]
Immutep Announces European Patent Grant for Eftilagimod Alpha in Chemo-Immunotherapy
23/05/2019
SYDNEY, Australia, May 23, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]
RedHill Biopharma to Present at 2019 BIO International Convention
23/05/2019
TEL-AVIV, Israel and RALEIGH, N.C., May 23, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL ) (Tel-Aviv Stock Exchange: RDHL ) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
BioSig Allowed First Key US Patent Claims for its PURE EP™ System
23/05/2019
Santa Monica, CA, May 23, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Albireo Announces Data on Pediatric Cholestatic Liver Diseases to be Presented at the 2019 ESPGHAN Annual Meeting
23/05/2019
BOSTON, May 23, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that clinical data and [...]
Orchestra BioMed™ Presents Clinical Data at EuroPCR 2019 Demonstrating Safety and Efficacy of BackBeat Cardiac Neuromodulation Therapy (CNT)
23/05/2019
Novel implantable bioelectronic treatment delivers immediate, substantial, and sustained reduction in blood pressure Data showed 14.2 mmHg reduction in 24-hour ambulatory systolic blood pressure at three months and 23.4 [...]

Pages